Company
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
Headquarters: Verdellino, BG, Italy
Employees: 607
CEO: Mr. Marco Francesco Eigenmann
Market Cap
€169.9 Million
EUR as of Jan. 1, 2025
US$176.8 Million
Fine Foods & Pharmaceuticals N.T.M. S.p.A. Categories
Italy Healthcare Drug Manufacturers—Specialty & GenericItaly Healthcare Italy Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract development and manufacturing of oral solid forms for the pharmaceutical and nutraceutical industries. Its pharmaceutical products include powders and granules, tablets, film-coated tablets, and hard gelatine capsules; and nutraceutical products comprise soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, film-coated tablets, and hard gelatin capsules. The company also develops and manufactures medical devices for gastrointestinal treatment, oral and throat treatment, and weight management. Fine Foods & Pharmaceuticals N.T.M. S.p.A. was founded in 1984 and is based in Verdellino, Italy.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Fine Foods & Pharmaceuticals N.T.M. S.p.A. has the following listings and related stock indices.
Stock: MTA: FF wb_incandescent